GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Inventory-to-Revenue

Amin Pharmaceutical Co (XTEH:AMIN1) Inventory-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Amin Pharmaceutical Co's Average Total Inventories for the quarter that ended in . 20 was IRR0.00 Mil. Amin Pharmaceutical Co's Revenue for the six months ended in . 20 was IRR0.00 Mil.

Amin Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in . 20 stayed the same from . 20 (0.00) to . 20 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Amin Pharmaceutical Co Inventory-to-Revenue Historical Data

The historical data trend for Amin Pharmaceutical Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co Inventory-to-Revenue Chart

Amin Pharmaceutical Co Annual Data
Trend
Inventory-to-Revenue

Amin Pharmaceutical Co Semi-Annual Data
Inventory-to-Revenue

Competitive Comparison of Amin Pharmaceutical Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Amin Pharmaceutical Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amin Pharmaceutical Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amin Pharmaceutical Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Amin Pharmaceutical Co's Inventory-to-Revenue falls into.



Amin Pharmaceutical Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Amin Pharmaceutical Co's Inventory-to-Revenue for the fiscal year that ended in . 20 is calculated as

Inventory-to-Revenue (A: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Revenue (A: . 20 )
=( ( + ) / 1 ) /
=0 /
=N/A

Amin Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue (Q: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Revenue (Q: . 20 )
=( ( + ) / 1 ) /
=0 /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amin Pharmaceutical Co  (XTEH:AMIN1) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Amin Pharmaceutical Co's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory=Average Total Inventories (Q: . 20 )/Cost of Goods Sold (Q: . 20 )*Days in Period
=0/*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Amin Pharmaceutical Co's Inventory Turnover for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amin Pharmaceutical Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines